EGCG对非肥胖型糖尿病大鼠肾损伤的改善作用及调节机制研究

doi:10.13305/j.cnki.jts.2023.06.003

茶叶科学 ›› 2023, Vol. 43 ›› Issue (6): 784-794.doi: 10.13305/j.cnki.jts.2023.06.003

EGCG对非肥胖型糖尿病大鼠肾损伤的改善作用及调节机制研究

彭丽媛, 曾鸿哲, 万丽玮, 文帅, 刘昌伟, 安勤, 鲍肃都, 黄建安^*, 刘仲华^*

湖南农业大学茶学教育部重点实验室,国家植物功能成分利用工程技术研究中心,植物功能成分利用省部共建协同创新中心,农业农村部园艺作物基因资源评价利用重点实验室,湖南长沙 410128

收稿日期:2023-09-11 修回日期:2023-11-05 出版日期:2023-12-15 发布日期:2024-01-08
通讯作者: *Jian7513@hunau.edu.cn;larkin-liu@163.com
作者简介:彭丽媛,女,硕士研究生,研究方向为茶叶功能成分利用与深加工。
基金资助:
国家茶叶产业技术体系（CARS19）、茶叶功能成分优异资源高效利用技术研究（湘财农指[2021]0015号）

The Investigation of the Ameliorate Effect and Mechanism of EGCG on Non-obese GK Rat with Diabetic Kidney Damage

PENG Liyuan, ZENG Hongzhe, WAN Liwei, WEN Shuai, LIU Changwei, AN Qin, BAO Sudu, HUANG Jian'an^*, LIU Zhonghua^*

Key Lab of Education Ministry of Hunan Agricultural University for Tea Science, National Research Center of Engineering and Technology for Utilization of Botanical Functional Ingredients, Co-Innovation Center of Education Ministry for Utilization of Botanical Functional Ingredients, Key Laboratory for Evaluation and Utilization of Gene Resources of Horticultural Crops, Ministry of Agriculture and Rural Affairs of China, Changsha 410128, China

Received:2023-09-11 Revised:2023-11-05 Online:2023-12-15 Published:2024-01-08

摘要/Abstract

摘要： EGCG是一种抗氧化、抗炎症的天然活性成分,目前关于EGCG的抗氧化和抗炎症作用在糖尿病肾损伤中的作用及调节机制研究较少。采用不同剂量的EGCG干预非肥胖型糖尿病Goto-Kakizaki（GK）大鼠以探究EGCG对糖尿病大鼠肾损伤的作用和机制。试验周期为4周,监测试验期内大鼠的平均体质量和日平均摄食量,并在试验结束后取血清和肾脏组织,检测大鼠肾功能、肾脏病理指标、氧化应激和炎症指标以及Nrf2-Keap1/MAPK信号通路相关基因表达水平。试验表明,EGCG能够有效改善GK大鼠肾脏形态损伤,显著降低血肌酐、尿素氮和肾脏丙二醛含量,提高肾脏超氧化物歧化酶、过氧化氢酶和谷胱甘肽过氧化物酶等抗氧化酶活性,抑制促炎因子单核细胞趋化蛋白-1和白介素-1β的释放水平,调节与抗氧化应激相关的Nrf2-Keap1/MAPK信号通路的Nrf2、Keap1、JNK、NF-κB、P38基因表达水平,且在试验范围内,高剂量的改善效果优于低剂量。以上结果表明,EGCG对大鼠糖尿病导致的肾损伤有一定的改善作用,其作用机理可能与Nrf2-Keap1/MAPK信号通路介导的抗氧化应激有关。

关键词: EGCG, 糖尿病肾损伤, 氧化应激, 炎症, 糖尿病, GK大鼠

Abstract: Epigallocatechin gallate (EGCG) is an antioxidant and anti-inflammatory natural active ingredient, and fewer studies have been conducted on the antioxidant and anti-inflammatory effects of EGCG in DKD and the regulatory mechanisms. This study investigated the effect and mechanism of EGCG on diabetic kidney damage in non-obese GK rats with idiopathic T2DM. Two different doses of EGCG (10 mg·kg^-1 and 120 mg·kg^-1) were administered to GK rats for 4 weeks. The body weight and daily food intake of rats were monitored during the experiment. At the end of the experiment, the serum and kidney tissues were collected to detect some kidney biochemical and pathological indicators and Nrf2-Keap1/MAPK signaling pathway related gene expression levels. The results show that EGCG could improve the kidney morphology and significantly increase the activities of antioxidant enzymes (such as SOD, CAT and GSH-Px), and inhibit the release of proinflammatory cytokines (MCP-1, IL-1β). In addition, EGCG could restrain oxidant stress by up-regulate the expression level of Nrf2 and inhibit inflammation by down-regulating the expression levels of JNK, NF-κB and P38 genes in kidney. The improvement effect of high dose was better than that of low dose in the experimental range. In conclusion, these results indicate that EGCG could ameliorate kidney injury caused by diabetes, and its mechanism might be related to anti-oxidative stress mediated by Nrf2-Keap1/MAPK signaling pathways.

Key words: EGCG, diabetic kidney damage, oxidant stress, inflammation, diabetes, GK rats

中图分类号:

彭丽媛, 曾鸿哲, 万丽玮, 文帅, 刘昌伟, 安勤, 鲍肃都, 黄建安, 刘仲华. EGCG对非肥胖型糖尿病大鼠肾损伤的改善作用及调节机制研究[J]. 茶叶科学, 2023, 43(6): 784-794. doi: 10.13305/j.cnki.jts.2023.06.003.

PENG Liyuan, ZENG Hongzhe, WAN Liwei, WEN Shuai, LIU Changwei, AN Qin, BAO Sudu, HUANG Jian'an, LIU Zhonghua. The Investigation of the Ameliorate Effect and Mechanism of EGCG on Non-obese GK Rat with Diabetic Kidney Damage[J]. Journal of Tea Science, 2023, 43(6): 784-794. doi: 10.13305/j.cnki.jts.2023.06.003.

参考文献 25

[1]	李长平. 慢性肾脏病患者如何科学摄取营养[J]. 保健医苑, 2019(3): 16-17.Li C P.How does patients with chronic kidney disease take nutrition scientifically[J]. Health Care, 2019(3): 16-17.
[2]	Ruiz-Ortega M, Rodrigues-Diez R R, Lavoz C, et al. Special issue "diabetic nephropathy: diagnosis, prevention and treatment"[J]. Journal of Clinical Medicine, 2020, 9(3): 813. doi: doi.org/10.3390/jcm9030813.
[3]	Ross S A.Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetes[J]. The American Journal of Medicine, 2013, 126(9s1): S38-S48.
[4]	Wan C P, Ouyang J, Li M X, et al.Effects of green tea polyphenol extract and epigallocatechin-3-O-gallate on diabetes mellitus and diabetic complications: recent advances [J/OL]. Critical Reviews in Food Science and Nutrition, 2022: 1-29. doi: 10.1080/10408398.2022.2157372.
[5]	尹昀东, 方朝晖, 尤良震. GK大鼠生物学特性及其在糖尿病相关模型制备中应用的研究进展[J]. 山东医药, 2018, 58(46): 86-89.Yin Y D, Fang Z H, You L Z.Research progress on biological characteristics of GK rats and its application in the preparation of diabetes-related models[J]. Shandong Medical Journal, 2018, 58(46): 86-89.
[6]	Kojima N, Slaughter T N, Paige A, et al.Comparison of the development diabetic induced renal disease in strains of Goto-Kakizaki rats[J]. Journal of Diabetes & Metabolism, 2013, 37(s9): 5. doi: 10.4172/2155-6156.S9-005.
[7]	Zhang Z T, Guo N, Zhuang G D, et al.Metabolic profiling of carbonyl compounds for unveiling protective mechanisms of Pueraria lobata against diabetic nephropathy by UPLC-Q-Orbitrap HRMS/MS analysis[J]. Journal of Agricultural and Food Chemistry, 2021, 69(37): 10943-10951.
[8]	Yang Z, Zhu M Z, Zhang Y B, et al.Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats[J]. Phytotherapy Research, 2019, 33(4): 1019-1026.
[9]	文馨月, 唐雪阳, 何丹, 等. 中药调节肠道菌群与代谢产物改善高尿酸血症研究进展[J]. 中国中药杂志, 2021, 46(24): 6387-6394.Wen X Y, Tang X Y, He D, et al.Research progress on anti-hyperuricemia effects and mechanisms of Chinese medicines based on regulation of intestinal flora and metabolites[J]. China Journal of Chinese Materia Medica, 2021, 46(24): 6387-6394.
[10]	郭立新. 2021年糖尿病领域年度重大进展回顾[J]. 中华糖尿病杂志, 2022, 14(1): 1-8.Guo L X.2021 annual review of major progress in diabetes[J]. Chinese Journal of Diabetes Mellitus, 2022, 14(1): 1-8.
[11]	Zhang X X, Kong J, Yun K.Prevalence of diabetic nephropathy among patients with type 2 diabetes mellitus in China: a meta-analysis of observational studies[J]. Journal of Diabetes Research, 2020, 2020: 2315607. doi: 10.1155/2020/2315607.
[12]	中华医学会肾脏病学分会专家组. 糖尿病肾脏疾病临床诊疗中国指南[J]. 中华肾脏病杂志, 2021, 37(3): 255-304.Chinese Society of Nephrology Expert Group. Chinese guidelines for diagnosis and treatment of diabetic kidney disease[J]. Chinese Journal of Nephrology, 2021, 37(3): 255-304.
[13]	Fioretto P, Mauer M.Diabetic nephropathy: diabetic nephropathy-challenges in pathologic classification[J]. Nature Reviews Nephrology, 2010, 6(9): 508-510.
[14]	Xia X Y, Wang X D, Wang H, et al.Ameliorative effect of white tea from 50-year-old tree of Camellia sinensis L. (Theaceae) on kidney damage in diabetic mice via SIRT1/AMPK pathway[J]. Journal of Ethnopharmacology, 2021, 272: 113919. doi: 10.1016/j.jep.2021.113919.
[15]	Tanase D M, Gosav E M, Anton M I, et al.Oxidative stress and NRF2/KEAP1/ARE pathway in diabetic kidney disease (DKD): new perspectives[J]. Biomolecules, 2022, 12(9): 1227. doi: 10.3390/biom12091227.
[16]	Cao T, Zhang X, Yang D, et al.Antioxidant effects of epigallocatechin-3-gallate on the aTC1-6 pancreatic alpha cell line[J]. Biochemical and Biophysical Research Communications, 2018, 495(1): 693-699.
[17]	Coyle C H, Philips B J, Morrisroe S N, et al.Antioxidant effects of green tea and its polyphenols on bladder cells[J]. Life Sciences, 2008, 83(1/2): 12-18.
[18]	Yan J, Feng Z H, Liu J, et al.Enhanced autophagy plays a cardinal role in mitochondrial dysfunction in type 2 diabetic Goto-Kakizaki (GK) rats: ameliorating effects of (-)-epigallocatechin-3-gallate[J]. The Journal of Nutritional Biochemistry, 2012, 23(7): 716-724.
[19]	Surh Y J, Kundu J K, Na H K.Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals[J]. Planta Medica, 2008, 74(13): 1526-1539.
[20]	Wang D X, Wang Y J, Wan X C, et al.Green tea polyphenol (-)-epigallocatechin-3-gallate triggered hepatotoxicity in mice: responses of major antioxidant enzymes and the Nrf2 rescue pathway[J]. Toxicology and Applied Pharmacology, 2015, 283(1): 65-74.
[21]	Khan M A, Tania M, Zhang D Z, et al.Antioxidant enzymes and cancer[J]. Chinese Journal of Cancer Research, 2010, 22(2): 87-92.
[22]	Na H K, Surh Y J.Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG[J]. Food and Chemical Toxicology, 2008, 46(4): 1271-1278.
[23]	Ginn-Pease M E, Whisler R L. Redox signals and NF-kappaB activation in T cells[J]. Free Radical Biology &Medicine, 1998, 25(3): 346-361.
[24]	周继红, 陈蔚, 丁乐佳, 等. EGCG改善高果糖饮食小鼠代谢紊乱的作用与机制研究[J]. 茶叶科学, 2023, 43(3): 399-410.Zhou J H, Chen W, Ding L J, et al.Regulatory effect and mechanism of EGCG on metabolic disorders in high-fructose diet mice[J]. Journal of Tea Science, 2023, 43(3): 399-410.
[25]	Uchiyama Y, Suzuki T, Mochizuki K, et al.Dietary supplementation with (-)-epigallocatechin-3-gallate reduces inflammatory response in adipose tissue of non-obese type 2 diabetic Goto-Kakizaki (GK) rats[J]. Journal of Agricultural and Food Chemistry, 2013, 61(47): 11410-11417.

EGCG对非肥胖型糖尿病大鼠肾损伤的改善作用及调节机制研究

The Investigation of the Ameliorate Effect and Mechanism of EGCG on Non-obese GK Rat with Diabetic Kidney Damage

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 25

相关文章 15

Metrics

本文评价

推荐阅读 10

[1]	万丽玮, 曾鸿哲, 彭丽媛, 文帅, 刘昌伟, 鲍肃都, 安勤, 黄建安, 刘仲华. EGCG对高脂饮食GK大鼠白色脂肪米色化的诱导作用与机制研究[J]. 茶叶科学, 2024, 44(1): 119-132.
[2]	曾鸿哲, 彭丽媛, 万丽玮, 刘昌伟, 方雯雯, 王阔飞, 张欣仪, 文帅, 黄建安, 刘仲华. 基于肝脏转录组学探究发花红茶降血糖作用的潜在机制[J]. 茶叶科学, 2023, 43(5): 645-656.
[3]	盛政, 杜文凯, 王崇崇, 张博安, 张海华, 杜琪珍. 茶多酚对茶食品中还原糖检测方法的影响[J]. 茶叶科学, 2023, 43(4): 567-575.
[4]	周继红, 陈蔚, 丁乐佳, 王岳飞. EGCG改善高果糖饮食小鼠代谢紊乱的作用与机制研究[J]. 茶叶科学, 2023, 43(3): 399-410.
[5]	陈珂, 王苑竹, 杨晓颖, 张冬英, 朱强强. 壳聚糖复合β-乳球蛋白负载EGCG纳米粒的制备及其对糖尿病小鼠血糖的影响[J]. 茶叶科学, 2022, 42(5): 731-739.
[6]	俞蓉欣, 郑芹芹, 陈红平, 张劲松, 张相春. 儿茶素生物医用纳米材料研究进展[J]. 茶叶科学, 2022, 42(4): 447-462.
[7]	张旖旎, 吉铮. 表没食子儿茶素没食子酸酯（EGCG）研究的文献计量分析[J]. 茶叶科学, 2022, 42(3): 423-434.
[8]	代昕玥, 葛炳钢, 张旭雯, 刘文武, 段继春, 傅冬和. 茯砖茶改善2型糖尿病小鼠代谢紊乱的效果研究[J]. 茶叶科学, 2022, 42(1): 63-75.
[9]	邓志慧, 曾洁, 付红娟, 常徽. 茶黄素-3,3'-O-双没食子酸酯对糖尿病大鼠血管内皮损伤及炎症反应的保护作用[J]. 茶叶科学, 2021, 41(6): 823-830.
[10]	曾洁, 邓志慧, 付红娟, 刘畅, 古仪, 邹奕昕, 常徽. 茶黄素激活Nrf2/HO-1通路保护血管内皮细胞氧化应激损伤[J]. 茶叶科学, 2020, 40(5): 632-640.
[11]	黎攀, 周辉, 蔡梅生, 金恩惠, 刘晓博, 何普明, 屠幼英. 白茶对烟雾诱导的小鼠慢性阻塞性肺病的改善研究[J]. 茶叶科学, 2020, 40(5): 641-655.
[12]	姚敏, 李大祥, 谢忠稳. 茶叶主要特征性化合物抗心血管炎症研究进展[J]. 茶叶科学, 2020, 40(1): 1-14.
[13]	张建勇, 陈琳, 崔宏春, 王伟伟, 薛金金, 熊春华, 江和源. PBD和RSM联用优化聚酯型儿茶素A化学合成技术参数[J]. 茶叶科学, 2020, 40(1): 51-62.
[14]	胡安恺, 姚立筠, 赵悦伶, 刘畅, 王岳飞, 徐平. 茯砖茶提取物对葡聚糖硫酸钠诱导小鼠炎症性肠病的保护作用研究[J]. 茶叶科学, 2019, 39(6): 641-651.
[15]	史春麟, 李晓焕, 黄翔翔. 绿茶多酚对被动吸烟引起小鼠肺氧化应激的干预研究[J]. 茶叶科学, 2018, 38(2): 212-220.